Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography

A reversed phase high performance liquid chromatographic (RP-HPLC) method for the simultaneous determination of tolperisone (TP) and lidocaine (LD) has been developed. The drugs were separated on a column (4.60 × 250 mm2) Spherisorb ODS (5 μm) using 5.5% triethylamine in 70/30 v/v acetonitrile/water...

Full description

Saved in:
Bibliographic Details
Main Authors: Liawruangrath S., Liawruangrath B., Pibool P.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-0034793438&partnerID=40&md5=b9bb9c1272ef6222d328799b23756ddc
http://www.ncbi.nlm.nih.gov/pubmed/11600298
http://cmuir.cmu.ac.th/handle/6653943832/4613
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-4613
record_format dspace
spelling th-cmuir.6653943832-46132014-08-30T02:42:39Z Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography Liawruangrath S. Liawruangrath B. Pibool P. A reversed phase high performance liquid chromatographic (RP-HPLC) method for the simultaneous determination of tolperisone (TP) and lidocaine (LD) has been developed. The drugs were separated on a column (4.60 × 250 mm2) Spherisorb ODS (5 μm) using 5.5% triethylamine in 70/30 v/v acetonitrile/water as mobile phase 0.7 ml min -1and UV detection at 254 nm. The detection limits for Tolperisone hydrochloride (TP·HCl) and lidocaine hydrochloride (LD·HCl) were 0.20 ng/20 μl and 100 ng/20 μl and the quantitation limits were 0.50 ng/20 μl and 250 ng/20 μl, respectively. Linear calibration curves over the ranges of 1-10, 10-100 and 150-500 μg ml-1 for TP·HCl and 10-500 μg ml-1 for LD·HCl were established. Different calibration slopes were found for TP probably owing to changes in refractive index due to increase in TP concentration. The average recoveries of the added TP in the samples (TP·HCl tablets and injection liquid). A solutions spiked with standard TP·HCl were 99.9 and 99.7% with the RSD (n = 11) of 0.66 and 0.67%, respectively. The average recovery of the added LD in the sample (injection) spiked with standard LD·HCl was 98.9% with the RSD (n = 11) of 0.59%. The proposed method has been applied to the determination of TP·HCl and LD·HCl in commercial products available in Thailand. Comparative determination of TP by UV spectrophotometry and LD by colorimetry were also carried out. The results obtained by both methods were in good agreement of those obtained by the proposed method verified by using t-test. The proposed RP-HPLC method is simple, accurate, reproducible and suitable for routine analysis. © 2001 Elsevier Science B.V. All rights reserved. 2014-08-30T02:42:39Z 2014-08-30T02:42:39Z 2001 Article 07317085 10.1016/S0731-7085(01)00462-9 11600298 JPBAD http://www.scopus.com/inward/record.url?eid=2-s2.0-0034793438&partnerID=40&md5=b9bb9c1272ef6222d328799b23756ddc http://www.ncbi.nlm.nih.gov/pubmed/11600298 http://cmuir.cmu.ac.th/handle/6653943832/4613 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description A reversed phase high performance liquid chromatographic (RP-HPLC) method for the simultaneous determination of tolperisone (TP) and lidocaine (LD) has been developed. The drugs were separated on a column (4.60 × 250 mm2) Spherisorb ODS (5 μm) using 5.5% triethylamine in 70/30 v/v acetonitrile/water as mobile phase 0.7 ml min -1and UV detection at 254 nm. The detection limits for Tolperisone hydrochloride (TP·HCl) and lidocaine hydrochloride (LD·HCl) were 0.20 ng/20 μl and 100 ng/20 μl and the quantitation limits were 0.50 ng/20 μl and 250 ng/20 μl, respectively. Linear calibration curves over the ranges of 1-10, 10-100 and 150-500 μg ml-1 for TP·HCl and 10-500 μg ml-1 for LD·HCl were established. Different calibration slopes were found for TP probably owing to changes in refractive index due to increase in TP concentration. The average recoveries of the added TP in the samples (TP·HCl tablets and injection liquid). A solutions spiked with standard TP·HCl were 99.9 and 99.7% with the RSD (n = 11) of 0.66 and 0.67%, respectively. The average recovery of the added LD in the sample (injection) spiked with standard LD·HCl was 98.9% with the RSD (n = 11) of 0.59%. The proposed method has been applied to the determination of TP·HCl and LD·HCl in commercial products available in Thailand. Comparative determination of TP by UV spectrophotometry and LD by colorimetry were also carried out. The results obtained by both methods were in good agreement of those obtained by the proposed method verified by using t-test. The proposed RP-HPLC method is simple, accurate, reproducible and suitable for routine analysis. © 2001 Elsevier Science B.V. All rights reserved.
format Article
author Liawruangrath S.
Liawruangrath B.
Pibool P.
spellingShingle Liawruangrath S.
Liawruangrath B.
Pibool P.
Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
author_facet Liawruangrath S.
Liawruangrath B.
Pibool P.
author_sort Liawruangrath S.
title Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
title_short Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
title_full Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
title_fullStr Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
title_full_unstemmed Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
title_sort simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-0034793438&partnerID=40&md5=b9bb9c1272ef6222d328799b23756ddc
http://www.ncbi.nlm.nih.gov/pubmed/11600298
http://cmuir.cmu.ac.th/handle/6653943832/4613
_version_ 1681420270140653568